BCL-2 oncoprotein (p26) in splenic lymphoma with villous lymphocytes: A comparative study with other chronic B-cell disorders

• Type: Article in International Scientific Journal
• Date: 1997

Authors

Lima, M (Author) Other; Teixeira, MD (Author) Other; Queiros, ML (Author) Other; dosSantos, AHR (Author) Other; Justica, B (Author) Other

Journal

Title: American Journal of Hematology

Vol. 56

Pages: 122-125

ISSN: 0361-8609

Publisher: Wiley-Blackwell

Indexing

ISI Web of Knowledge - 3 Citations

Scopus - 3 Citations

Other information

Authenticus ID: P-001-AG6

DOI: 10.1002/(sici)1096-8652(199710)56:2<122::aid-ajh9>3.0.co;2-0

Abstract (EN): We compared the expression of the BCL-2 oncoprotein (p26) on B cells from 24 patients with splenic lymphoma with circulating villous lymphocytes (SLVL) with that observed on normal, mature B lymphocytes and on neoplastic B cells from 91 patients with other chronic Ei-cell malignancies. SLVL B cells showed levels of p26 intermediate between those found on normal B lymphocytes and on neoplastic B cells from patients with other chronic B-cell lymphoproliferative disorders. (C) 1997 Wiley-Liss, Inc.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 4